Luca Petrasso

Ask VT AI
View News Summary
  • Roper Technologies reports strong Q3 results, with revenue and earnings growth, and announces new acquisitions and a share buyback program.
  • Renault Group posts strong Q3 2025 results driven by surging EV and hybrid sales, confirming its 2025 financial outlook.
  • Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Roper Technologies reports strong Q3 results, with revenue and earnings growth, and announces new acquisitions and a share buyback program.
  • Renault Group posts strong Q3 2025 results driven by surging EV and hybrid sales, confirming its 2025 financial outlook.
  • Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Luca Petrasso